| Natera, Inc. Common Stock | $38.9b | $275.51 | -0.5% | 370.3K | |
| Illumina Inc | $26.6b | $189.70 | +1.2% | 505.6K | |
| Labcorp Holdings Inc. | $23.0b | $278.76 | +2.3% | 207.9K | |
| QIAGEN N.V. | $8.1b | $41.44 | +0.3% | 1.2M | |
| BillionToOne, Inc. Class A Common Stock | $5.5b | $128.31 | -1.6% | 409.3K | |
| 10x Genomics, Inc. Class A Common Stock | $4.9b | $42.85 | -7.1% | 2.5M | |
| Veracyte, Inc. | $4.7b | $59.45 | -0.2% | 413.9K | |
| GeneDx Holdings Corp. Class A Common Stock | $2.0b | $62.94 | -5.3% | 299.6K | |
| NeoGenomics, Inc. | $1.9b | $14.59 | +0.8% | 2.2M | |
| CareDx, Inc. | $1.5b | $39.04 | +28.7% | 3.2M | |
| Personalis, Inc. Common Stock | $1.4b | $14.98 | -5.9% | 3.1M | |
| Azenta, Inc. | $1.2b | $26.64 | -0.4% | 246.3K | |
| Opko Health Inc. | $1.1b | $1.20 | -0.4% | 2.6M | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $20.78 | -1.3% | 106.5K | |
| Mesa Laboratories Inc | $0.6b | $96.56 | +2.6% | 111.5K | |
| Myriad Genetics Inc | $0.5b | $6.21 | -2.0% | 496.9K | |
| Pacific Biosciences of California, Inc. | $0.5b | $1.48 | -3.6% | 2.9M | |
| Prenetics Global Limited Class A Ordinary Share | $325.0m | $17.99 | -7.7% | 293.3K | |
| Insight Molecular Diagnostics Inc. Common Stock | $190.5m | $4.66 | -2.5% | 75.6K | |
| ALPS Group Inc Ordinary Share | $96.5m | $0.46 | -1.6% | 50.6K | |
| Quantum Cyber N.V. Ordinary Shares | $35.7m | $1.15 | -6.9% | 1.4M | |
| Bionano Genomics, Inc. Common Stock | $13.0m | $1.18 | 0.0% | 27.7K | |
| BioNexus Gene Lab Corp Common stock | $4.7m | $1.75 | 0.0% | 3.6K |